Paramount Skydance reportedly proposes EU concessions tied to its $110 billion bid for Warner Bros. Discovery

Paramount Skydance has reportedly offered concessions aimed at resolving concerns raised by the European Union as it seeks approval for its roughly $110 billion deal to acquire Warner Bros. Discovery, according to market chatter published July 1, 2026.

The report frames the move as a response to antitrust scrutiny in Europe, where competition authorities typically assess whether major media mergers could reduce choice for consumers, raise prices for advertisers, or weaken the negotiating position of pay-TV and streaming distributors.

Under the reported proposal, Paramount Skydance would make adjustments described as remedies, a term regulators use for concrete commitments intended to mitigate competitive harms. In merger cases, these can range from behavioral commitments, such as restrictions on bundling or licensing practices, to structural measures, such as divestitures of specific assets.

For Warner Bros. Discovery, the development matters because the company is a central target in a transaction that, if approved, would reshape its portfolio of entertainment and news brands as well as the scale and bargaining power of the combined firm in distribution negotiations across Europe.

The report also highlights the size of the transaction as a factor behind the intensity of regulatory review. A $110 billion valuation would place the deal among the most consequential media combinations of the decade, increasing the likelihood that regulators will pursue detailed remedies to address market structure and leverage concerns.

However, the market-chatter post did not provide granular details on what remedies Paramount Skydance is offering, how the concessions would work in practice, or whether the proposals specifically target certain channels, streaming catalogs, or advertising relationships.

In addition, the report did not clarify whether the EU has issued a formal statement of objections or an updated negotiating timeline, nor did it indicate whether the company or regulators have agreed to proceed into any next phase of the review.

What to watch next is whether any formal EU communications confirm the presence and scope of the proposed remedies, and whether the parties move from informal negotiation into documented commitments. Any public steps, including submissions to regulators or updated regulatory schedules, would offer the clearest read-through on how close the deal is to clearing European hurdles.